PD-1+JAK1i: Clinical Trials

1 trial of PD-1+JAK1i, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow PD-1+JAK1i: new trials by email Literature Review of PD-1+JAK1i trials Research Report on PD-1+JAK1i

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma
PD-1+JAK1i, PD-1 - Hodgkin Lymphoma
Phase 1 / Phase 2Not yet recruitingShanghai Jiao Tong University School of Medicine1122026-06-302026-06-11

Conditions studied

Hodgkin Disease (1)

Sponsors

Shanghai Jiao Tong University School of Medicine (1)

Countries

China (1)